Alpha-melanocyte-stimulating hormone contributes to an anti-inflammatory response to lipopolysaccharide.

OBJECTIVE

During infection, metabolism and immunity react dynamically to promote survival through mechanisms that remain unclear. Pro-opiomelanocortin (POMC) cleavage products are produced and released in the brain and in the pituitary gland. One POMC cleavage product, alpha-melanocyte-stimulating hormone (α-MSH), is known to regulate food intake and energy expenditure and has anti-inflammatory effects. However, it is not known whether α-MSH is required to regulate physiological anti-inflammatory responses. We recently developed a novel mouse model with a targeted mutation in Pomc (Pomc mice) to block production of all α-MSH forms which are required to regulate metabolism. To test whether endogenous α-MSH is required to regulate immune responses, we compared acute bacterial lipopolysaccharide (LPS)-induced inflammation between Pomc and wild-type Pomc mice.

METHODS

We challenged 10- to 14-week-old male Pomc and Pomc mice with single i.p. injections of either saline or low-dose LPS (100 μg/kg) and monitored immune and metabolic responses. We used telemetry to measure core body temperature (T), ELISA to measure circulating cytokines, corticosterone and α-MSH, and metabolic chambers to measure body weight, food intake, activity, and respiration. We also developed a mass spectrometry method to measure three forms of α-MSH produced in the mouse hypothalamus and pituitary gland.

RESULTS

LPS induced an exaggerated immune response in Pomc compared to Pomc mice. Both groups of mice were hypoactive and hypothermic following LPS administration, but Pomc mice were significantly more hypothermic compared to control mice injected with LPS. Pomc mice also had reduced oxygen consumption and impaired metabolic responses to LPS compared to controls. Pomc mice had increased levels of key proinflammatory cytokines at 2 h and 4 h post LPS injection compared to Pomc mice. Lastly, Pomc mice injected with LPS compared to saline had increased total α-MSH in circulation 2 h post injection.

CONCLUSIONS

Our data indicate endogenous α-MSH contributes to the inflammatory immune responses triggered by low-dose LPS administration and suggest that targeting the melanocortin system could be a potential therapeutic for the treatment of sepsis or inflammatory disease.